SciELO - Scientific Electronic Library Online

 
vol.29 número1Asma infanto-juvenil y trastornos psiquiátricosRecomendaciones para el diagnóstico, manejo y prevención de la influenza en Chile: Período 2013 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista chilena de enfermedades respiratorias

versión On-line ISSN 0717-7348

Resumen

BELLO S, Sergio; CHAMORRO R, Haydee  y  BARRIENTOS R, Andrea. Smoking cessation in patients with chronic obstructive pulmonary disease. Rev. chil. enferm. respir. [online]. 2013, vol.29, n.1, pp.24-30. ISSN 0717-7348.  http://dx.doi.org/10.4067/S0717-73482013000100004.

In COPD patients, smoking worsens lung function and smoking cessation reduces the fall in FEV1 and all-cause of mortality. There is a high percentage of these patients who continues smoking despite the disease due to the high degree of dependence, low motivation to quit and association with depression and false beliefs, which hampers attempts to stop smoking and reduce their success. The smoker 's treatment has two pillars: psychosocial intervention and pharmacological treatment. In COPD patients ' psychosocial intervention should be especially intense, empathic and aimed at increasing motivation and self-efficacy, using Motivational Interviewing. In pharmacotherapy, first-line drugs are nicotine replacement (NRT), bupropion and varenicline. In patients with COPD, NRT is effective and may be combined passive delivery NRT with other active delivery. Bupropion has been used, with cost-effectiveness. Varenicline in patients with mild to moderate COPD has been effective. In brief therapies for smokers with COPD should be more intense, combining pharmacological and psychosocial treatment and maintained over time.

Palabras clave : COPD; tobacco use; smoking cessation.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons